(HealthDay News) — People with HIV have about twice the risk of developing a non-AIDS cancer as members of the general population, a new report says. Men with HIV were 2.3 times more likely, while women with the virus are about 1.5 times more likely to develop these other cancers, according to a meta-analysis expected to be presented at the American Association for Cancer Research annual conference outside Washington, D.C. However,...  Read More »

Doctors in Berlin are reporting that they cured a man of AIDS by giving him transplanted blood stem cells from a person naturally resistant to the virus. But while the case has novel medical implications, experts say it will be of little immediate use in treating AIDS. Top American researchers called the treatment unthinkable for the millions infected in Africa and impractical even for insured patients in top research hospitals. “It’s...  Read More »

HIV-infected patients who began treatment earlier than is normally recommended lived longer than those who underwent the standard regimen, a study found. Patients who waited for levels of their immune cells to fall below recommended levels were 74 percent more likely to die in any year than those who started treatment earlier, said Mari Kitahata, a University of Washington AIDS researcher in Seattle who helped write the nationwide study...  Read More »

(sciencedaily.com) A more effective TB vaccine may help curtail the global spread of the disease, especially in HIV-positive people, for whom tuberculosis is the leading cause of death worldwide. The current vaccine against tuberculosis, called BCG, is administered to newborns in most countries in the world. However, in HIV-positive people, the vaccine can cause serious and even fatal disease later in life if HIV weakens the immune system,...  Read More »

WASHINGTON - Johnson and Johnson said Wednesday U.S. regulators have approved expanding use of its HIV drug Prezista to include patients who have not been treated with other drugs to control the virus. The FDA will now allow doctors to prescribe a once-daily dose of Prezista as part of HIV combination therapy in adults who have never before taken HIV medication.  Read the full story here:  FDA OKs expanded use of J&J drug for HIV patients...  Read More »

Keith Jerome has an idea for curing HIV that is both unorthodox and untested, which usually means it doesn’t get funded.  But thanks to a new initiative to stimulate bold approaches to global health, the University of Washington researcher will have a year and $100,000 to see whether his idea has promise. Jerome is one of 104 researchers around the world, including four from the UW, to receive the first Grand Challenges Explorations...  Read More »

 Read More »  Read More →

I snuggled into the cold leather couch in the lobby quietly waiting my turn. In a chair to the right of the sofa, a guy in his 20’s nervously fidgets; running his fingers through his dingy blonde hair, his leg shaking bouncing his arm perched on his knee. “This guy’s a wreck,” I say to myself trying to keep his personal chaos from upsetting me. This isn’t an easy thing to do but come on man, get a grip. It’s...  Read More »